Globus Medical, Inc. (GMED)

Globus Medical Stock Forecast

Stock Price Forecast

The 11 analysts with 12-month price forecasts for Globus Medical stock have an average target of 97.09, with a low estimate of 82 and a high estimate of 115. The average target predicts an increase of 34.69% from the current stock price of 72.09.

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$82	$97.09	$97	$115
Change	+13.75%	+34.69%	+34.56%	+59.53%

Analyst Ratings

The average analyst rating for Globus Medical stock from 13 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Oct '24	Nov '24	Dec '24	Jan '25	Feb '25	Mar '25
Strong Buy	5	6	6	5	4	4
Buy	4	4	5	5	5	5
Hold	3	3	2	3	4	4
Sell	0	1	1	0	0	0
Strong Sell	0	0	0	0	0	0
Total	12	14	14	13	13	13

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Richard Newitter Truist Securities	Truist Securities	Hold Maintains $90 → $82	Hold	Maintains	$90 → $82	+13.75%	Mar 18, 2025
David Saxon Needham	Needham	Hold Reiterates n/a	Hold	Reiterates	n/a	n/a	Mar 18, 2025
David Turkaly Citizens Capital Markets	Citizens Capital Markets	Hold Reiterates n/a	Hold	Reiterates	n/a	n/a	Feb 24, 2025
Matt Miksic Barclays	Barclays	Buy Maintains $100 → $103	Buy	Maintains	$100 → $103	+42.89%	Feb 24, 2025
Mathew Blackman Stifel	Stifel	Strong Buy Maintains $92 → $94	Strong Buy	Maintains	$92 → $94	+30.40%	Feb 21, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

2.74B

Increased by 8.56%

from 2.52B

Revenue Next Year

2.92B

Increased by 6.73%

from 2.74B

EPS This Year

3.50

Increased by 367.15%

from 0.75

EPS Next Year

4.01

Increased by 14.32%

from 3.50

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	789.04M	958.10M	1.02B	1.57B	2.52B	2.74B	2.92B	3.14B
Revenue Growth	0.47%	21.43%	6.76%	53.35%	60.62%	8.56%	6.73%	7.43%
EPS	1.01	1.44	1.85	1.07	0.75	3.50	4.01	4.59
EPS Growth	-33.55%	42.57%	28.47%	-42.16%	-29.91%	367.15%	14.32%	14.60%
Forward PE	-	-	-	-	-	20.57	18.00	15.70
No. Analysts	-	-	-	-	-	18	15	5

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029
High	2.8B	3.0B	3.3B
Avg	2.7B	2.9B	3.1B
Low	2.6B	2.8B	3.0B

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029
High	12.5%	10.9%	12.3%
Avg	8.6%	6.7%	7.4%
Low	4.0%	1.0%	2.2%

EPS Forecast

EPS	2025	2026	2027	2028	2029
High	3.78	4.52	4.92
Avg	3.50	4.01	4.59
Low	3.20	3.46	4.30

EPS Growth

EPS Growth	2025	2026	2027	2028	2029
High	404.1%	28.9%	23.0%
Avg	367.2%	14.3%	14.6%
Low	327.3%	-1.3%	7.4%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.